A recent study of a mouse mammary epithelial cell line (NMuMG) and a triple negative human breast cancer cell line MDAMB231 shows that CD44 couples with VCAM-1 in order to initiate EMT as well as chemoresistance (74). Here, CD44 is linked to breast cancer.